ACAD

ACADIA PHARMACEUTICALS INC

ACAD · CIK 1070494 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$1.1B
20182025
Net Income$0.4B
20182025
Operating CF$0.1B
20182025
Free Cash Flow$0.1B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$1.1B$1.0B$0.2B$0.1B$0.1B$0.4B$0.1B$0.1B
Cost of Revenue$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B—
Gross Profit——$0.2B$0.1B$0.1B$0.4B$0.1B$0.1B
R&D Expense$0.3B$0.3B$0.4B$0.4B$0.2B$0.3B$0.2B$0.2B
SG&A Expense$0.5B$0.5B$0.4B$0.4B$0.4B$0.4B$0.3B$0.3B
Operating Income$0.1B$0.2B$-0.1B$-0.2B$-0.2B$-0.3B$-0.2B$-0.2B
Net Income$0.4B$0.2B$0.0B$-0.0B$-0.0B$-0.3B$-0.1B$-0.1B
EPS (Basic)$2.32$1.37$0.28$-0.26————
EPS (Diluted)$2.30$1.36$0.28$-0.26————

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.6B$1.2B$0.7B$0.6B$0.7B$0.8B$0.8B$0.5B
Current Assets$1.1B$0.9B$0.6B$0.5B$0.6B$0.7B$0.8B$0.5B
Cash & Equivalents$0.2B$0.3B$0.2B$0.1B$0.1B$0.3B$0.2B$0.1B
Total Liabilities$0.3B$0.5B$0.3B$0.2B$0.2B$0.2B$0.1B$0.1B
Current Liabilities$0.3B$0.4B$0.3B$0.1B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$1.2B$0.7B$0.4B$0.4B$0.5B$0.6B$0.7B$0.5B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.1B$0.2B$0.0B$-0.1B$-0.1B$-0.1B$-0.2B$-0.2B
Investing Cash Flow$-0.3B$-0.0B$0.0B$0.1B$-0.1B$0.2B$-0.2B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B$0.4B$0.3B
← Companies